Back
Entrada Therapeutics Vs. Fulcrum Therapeutics Industry Stock Comparison
Buy
55
TRDA
Entrada Therapeutics
Last Price:
17.00
Seasonality Move:
6.92%
Sell
19
FULC
Fulcrum Therapeutics
Last Price:
3.71
Seasonality Move:
37.25%
Buy
55
Entrada Therapeutics (TRDA)
is a Buy
Is Entrada Therapeutics a Buy, Sell or Hold?
- The current Entrada Therapeutics [TRDA] share price is $16.44. The Score for TRDA is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
19
Fulcrum Therapeutics (FULC)
is a Sell
Is Fulcrum Therapeutics a Buy, Sell or Hold?
- The current Fulcrum Therapeutics [FULC] share price is $3.67. The Score for FULC is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- FULC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
TRDA Stock Price Chart
What is Entrada Therapeutics's stock price today?
-
The Entrada Therapeutics share price today is $16.44
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.
FULC Stock Price Chart
What is Fulcrum Therapeutics's stock price today?
-
The Fulcrum Therapeutics share price today is $3.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FULC is experiencing selling pressure, which indicates risk of future bearish movement.
TRDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 57.88 | Buy |
| Chaikin Money Flow: | 37888 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.46 - 16.34) | Buy |
| Bollinger Bands (100): | (14.55 - 16.63) | Buy |
FULC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.1 | Sell |
| Relative Strength Index (14 RSI): | 33.74 | Sell |
| Chaikin Money Flow: | -476921 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.88 - 7.74) | Sell |
| Bollinger Bands (100): | (5.41 - 9.21) | Sell |
TRDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.93 | Buy |
| 20-day SMA: | 15.16 | Buy |
| 50-day SMA: | 15.65 | Buy |
| 200-day SMA: | 14.78 | Buy |
| 8-day EMA: | 15.92 | Buy |
| 20-day EMA: | 15.59 | Buy |
| 50-day EMA: | 15.56 | Buy |
| 200-day EMA: | 15.05 | Buy |
FULC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.64 | Buy |
| 20-day SMA: | 4.52 | Sell |
| 50-day SMA: | 7.16 | Sell |
| 200-day SMA: | 7.82 | Sell |
| 8-day EMA: | 3.74 | Sell |
| 20-day EMA: | 4.61 | Sell |
| 50-day EMA: | 6.16 | Sell |
| 200-day EMA: | 7.08 | Sell |
Entrada Therapeutics Earnings Growth & TRDA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.
Fulcrum Therapeutics Earnings Growth & FULC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.40 per share, and a decrease next year of $0.79 per share.
Entrada Therapeutics Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Fulcrum Therapeutics Technical Analysis
| Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||